MedPath

Study of Blood Samples in Patients With Breast Cancer

Conditions
Breast Cancer
Registration Number
NCT00959556
Lead Sponsor
Centre Oscar Lambret
Brief Summary

RATIONALE: Studying the genes expressed in samples of blood from patients with cancer may help doctors identify biomarkers related to cancer. It may also help doctors predict how patients will respond to chemotherapy.

PURPOSE: This clinical trial is studying blood samples in patients with breast cancer.

Detailed Description

OBJECTIVES:

* Identify constitutional gene variants associated with a change in response.

OUTLINE: Blood samples are collected periodically for analysis of genetic factors.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
900
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Histologic complete response (Chevallier and Sataloff) or tumor response (RECIST)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre Oscar Lambret

🇫🇷

Lille, France

Centre Oscar Lambret
🇫🇷Lille, France
Jacques Bonneterre, MD, PhD
Contact
33-3-20-29-5959
j.bonneterre@o-lambret.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.